What should you know about amyloid A immunohistochemistry?

Short answer
Amyloid A immunohistochemistry is a laboratory stain used on tissue to help determine whether amyloid deposits contain amyloid A protein.
This answers one question. It is not a diagnosis and does not replace an assessment by a licensed doctor.
At a glance
- Sample
- A preserved section from a biopsy
- What it detects
- Binding of an antibody to amyloid A protein in tissue
- Main purpose
- To help classify confirmed amyloid deposits as AA type
- Key limitation
- The result must be interpreted with tissue findings and clinical information
The short answer
A pathologist applies an antibody to a biopsy section and examines where it binds. Staining within confirmed amyloid deposits supports classification as AA amyloidosis, but the finding must match the tissue appearance, other stains and the clinical picture.
What the result means
A positive result means the anti-amyloid A antibody has labelled material in the sample. When that labelling corresponds to deposits already shown to be amyloid, it supports the AA type, which can develop in the setting of ongoing inflammation. The stain does not by itself identify the underlying inflammatory condition or show how much an organ is affected.
A negative or unclear result does not settle every case. The sample may contain little deposit, staining may be technically difficult, or another amyloid protein may be present. The pathologist may compare Congo red staining, additional antibody stains and, when needed, a protein-typing method such as mass spectrometry.
This is a pathology classification test, not a general cancer test. Its significance depends on why the biopsy was taken, the organ sampled and the rest of the pathology report.
What to do after the report
Review the complete report with the clinician who ordered the biopsy. Confirm whether amyloid was demonstrated, whether amyloid A staining was positive, and whether the pathologist considers the type definite or recommends further testing.
If AA amyloidosis is supported, the next step is to look for and control a source of persistent inflammation while checking the organs that may be involved. Your clinician may use blood and urine tests, examination and imaging according to your symptoms and medical history. Treatment is directed at the underlying inflammatory driver and any organ problems; the stain itself does not select a treatment.
When to seek medical care
Contact your clinical team promptly if you develop new leg swelling, reduced urine output, worsening breathlessness, faintness, marked weakness or persistent vomiting or diarrhoea. These symptoms can have many causes, but they may signal fluid imbalance or kidney, heart or digestive involvement and should be assessed without waiting for a routine pathology appointment.
Seek emergency care for severe difficulty breathing, chest pain, collapse, confusion or very little urine with rapidly increasing swelling. Bring the pathology report or make it available electronically so the treating team can see the exact wording.
Questions for your doctor or pathologist
Ask whether the tissue definitely contains amyloid, whether amyloid A staining matches the deposits, and whether another typing test is needed. Also ask which organ checks are appropriate, what inflammatory cause is being considered, and who will coordinate follow-up if the result supports AA amyloidosis.
Questions people ask
What should you know about amyloid a immunohistochemistry?
It is an antibody-based stain performed on biopsy tissue to help determine whether confirmed amyloid deposits contain amyloid A protein. The pathologist interprets the staining pattern alongside Congo red and other findings.
Does a positive amyloid A stain diagnose cancer?
No. A positive stain supports AA-type amyloid in the sampled tissue; it does not on its own diagnose cancer or reveal the condition driving inflammation.
Can an unclear stain need more testing?
Yes. When staining is weak, conflicting or does not fit the tissue pattern, the pathology team may use additional stains or another protein-typing method before assigning an amyloid type.
Related
Related reading
Keep reading
Cancer care in the UAE
Hospitals & Medical Centers in Abu Dhabi
Most UAE cancer care is delivered inside hospital services rather than by standalone oncology clinics, so these are licensed hospitals & medical centers listed in Abu Dhabi. Confirm the specific cancer service exists before you travel, and know that asking for a second opinion is routine.
Ahalia Hospital Musaffah Building - Musaffah - Musaffah Industrial - Abu Dhabi - United Arab Emirates
Accepts: Daman, Thiqa, AXA, Cigna +26 more
Al Ruwais Industrial City - Abu Dhabi - United Arab Emirates
Accepts: Daman, Thiqa, AXA, Cigna +30 more
Abu Dhabi, Abu Dhabi
Accepts: Daman, Thiqa, AXA, Cigna +30 more
Second opinions are routine in cancer care and asking for one does not affect your treatment. How to arrange a second opinion in the UAE.
Ordered by verification status and how complete each clinic's public record is, then alphabetically. This is a directory listing, not a ranking — Zavis does not rate or recommend providers.
A factual listing drawn from the DHA, DOH and MOHAP licence registers. It is not a referral, an endorsement, or advice that any of these providers is right for you.
Medical disclaimer. This page is general health information, not medical advice, and it cannot diagnose you. Always consult a licensed healthcare provider about your own symptoms and treatment. In an emergency in the UAE, call 998 for an ambulance.